Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 131,003 | 140,714 | 105,734 | 81,553 | 120,914 |
| Marketable Securities | N/A | N/A | 71,865 | 121,898 | 130,426 |
| Receivables | 29,030 | 6,412 | 37,083 | 5,121 | 31,694 |
| Inventories | 23,937 | 25,397 | 27,335 | 17,173 | 40,696 |
| Other current assets | 0 | 0 | 0 | 65,776 | 0 |
| TOTAL | $244,529 | $209,459 | $278,167 | $331,559 | $364,108 |
| Non-Current Assets | |||||
| PPE Net | 7,603 | 10,917 | 12,166 | 4,785 | 14,512 |
| Investments And Advances | 5,806 | 6,912 | 5,776 | 0 | 4,534 |
| Other Non-Current Assets | 6,483 | 65,915 | 69,759 | 87,185 | 77,272 |
| TOTAL | $19,892 | $83,744 | $87,701 | $91,970 | $96,318 |
| Total Assets | $264,421 | $293,203 | $365,868 | $423,529 | $460,426 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 9,238 | 9,938 | 4,353 | 15,778 | 19,220 |
| Accrued Expenses | 151,141 | 113,574 | 164,286 | 132,987 | 170,986 |
| Other current liabilities | N/A | N/A | N/A | 43,516 | N/A |
| TOTAL | $190,530 | $148,589 | $196,733 | $217,668 | $209,415 |
| Non-Current Liabilities | |||||
| Long Term Debt | 72,779 | 72,478 | 72,213 | 71,934 | 71,666 |
| Deferred Revenues | 28,858 | 9,546 | 12,863 | 12,740 | 7,325 |
| Other Non-Current Liabilities | 98,073 | 152,797 | 157,439 | 160,051 | 161,821 |
| TOTAL | $297,071 | $356,467 | $376,770 | $389,540 | $387,693 |
| Total Liabilities | $487,601 | $505,056 | $573,503 | $607,208 | $597,108 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,031 | 4,016 | 3,979 | 3,951 | 3,934 |
| Common Shares | 1,008 | 1,004 | 995 | 988 | 983 |
| Retained earnings | -1,907,481 | -1,890,397 | -1,874,853 | -1,841,920 | -1,785,688 |
| Other shareholders' equity | 14,859 | 16,678 | 13,980 | 13,612 | 13,564 |
| TOTAL | $-223,180 | $-211,853 | $-207,635 | $-183,679 | $-136,682 |
| Total Liabilities And Equity | $264,421 | $293,203 | $365,868 | $423,529 | $460,426 |